Michael S Hearne Odonate Therapeutics, Inc. (ODTC) insider trading activity
Michael S Hearne is Chief Financial Officer of Odonate Therapeutics, Inc.. Currently has a direct ownership of 2,620 shares of ODTC, which is worth approximately $44.7 Million. The most recent transaction as insider was on Mar 15, 2021, when has been sold 37 shares (Common Stock) at a price of $16.22 per share, resulting in proceeds of $600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.62K
0%
3M change
0%
12M change
Total Value Held
$44.7 Million
Michael S Hearne Transaction History
Also insider at
MSH
Michael S Hearne
Chief Financial Officer
Waltham, MA